| |
| |
|
| Insider
Information: |
Vitullo Nicole |
| Relationship: |
10% Owner |
| City: |
Richmond |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
26 |
|
| Direct
Shares |
3,769,432 |
|
|
Indirect Shares
|
2,643,947 |
|
|
| Direct
Value |
$43,273,395 |
|
|
|
Indirect Value
|
$8,788,184 |
|
|
| Total
Shares |
6,413,379 |
|
|
| Total
Value |
$52,061,579 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -29.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-12 |
8,000 |
Premium* |
|
|
Onyx Pharmaceuticals Inc |
ONXX |
Director |
2005-07-28 |
668 |
2005-07-28 |
0 |
Premium* |
|
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
|
0 |
2006-12-21 |
19,379 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
|
0 |
2006-05-04 |
3,333 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
|
0 |
2006-05-09 |
100,355 |
Premium* |
|
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-28 |
5,142 |
2008-04-24 |
56,718 |
Premium* |
|
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
3,019 |
2011-12-22 |
50,643 |
Premium* |
|
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2010-04-27 |
0 |
2011-06-02 |
40,790 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
Director |
2020-01-28 |
0 |
2020-01-28 |
0 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
51,013 |
Premium* |
|
|
Durata Therapeutics, Inc. |
DRTX |
Director, 10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2023-06-15 |
36,918 |
2019-03-21 |
0 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2017-12-11 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
2016-11-01 |
0 |
2013-08-27 |
32,091 |
Premium* |
|
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
10% Owner |
2013-11-04 |
0 |
2013-11-04 |
22,730 |
Premium* |
|
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
2014-05-07 |
1,973,389 |
2014-05-01 |
0 |
Premium* |
|
|
Marinus Pharmaceuticals Inc |
MRNS |
Director |
2022-02-04 |
6,442 |
2021-03-16 |
0 |
Premium* |
|
|
Colucid Pharmaceuticals, Inc. |
CLCD |
10% Owner |
2016-09-09 |
0 |
|
0 |
Premium* |
|
|
Syndax Pharmaceuticals Inc |
SNDX |
10% Owner |
2016-03-08 |
1,743,854 |
2016-03-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
164 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OREX |
Orexigen Therapeutics, In... |
10% Owner |
– – • |
2009-07-23 |
4 |
B |
$7.50 |
$4,875,000 |
I/I |
650,000 |
19,138 |
1.5 |
- |
|
| ZGNX |
Zogenix, Inc. |
10% Owner |
– – • |
2011-09-16 |
4 |
B |
$2.00 |
$7,000,000 |
I/I |
3,500,000 |
169,251 |
1.5 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
Director |
– • • |
2012-07-24 |
4 |
B |
$9.00 |
$7,058,817 |
I/I |
784,313 |
22,306 |
2.25 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2013-07-15 |
4 |
B |
$6.03 |
$7,999,992 |
I/I |
1,327,491 |
1,897,336 |
1.5 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2013-07-15 |
4/A |
B |
$6.03 |
$7,999,992 |
I/I |
1,327,491 |
1,857,036 |
1.5 |
- |
|
| TBRA |
Tobira Therapeutics Inc |
10% Owner |
– – • |
2016-11-01 |
4 |
D |
$28.35 |
$8,099,000 |
D/D |
(285,679) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2017-08-10 |
4 |
D |
$5.06 |
$8,742,061 |
I/I |
(1,727,680) |
25,159 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2017-08-10 |
4 |
OE |
$3.11 |
$8,750,000 |
I/I |
2,811,245 |
37,885 |
0 |
- |
|
| ZGNX |
Zogenix, Inc. |
10% Owner |
– – • |
2010-11-29 |
4 |
B |
$4.00 |
$9,399,996 |
I/I |
2,349,999 |
110,555 |
1.5 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
10% Owner |
– – • |
2011-11-21 |
4 |
B |
$13.00 |
$12,111,879 |
I/I |
931,683 |
51,013 |
1.5 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2008-02-20 |
4 |
A |
$5.34 |
$14,999,996 |
I/I |
2,808,988 |
90,369 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2009-02-18 |
4 |
B |
$7.13 |
$19,826,206 |
I/I |
2,780,674 |
46,634 |
1.5 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2020-01-28 |
4 |
D |
$6.30 |
$21,536,808 |
I/I |
(3,418,541) |
0 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2014-03-19 |
4 |
D |
$14.00 |
$146,195,434 |
I/I |
(10,442,531) |
0 |
0 |
- |
|
164 Records found
|
|
Page 7 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
